Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: COLESTID

« Back to Dashboard
Colestid is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. It is available from four suppliers.

The generic ingredient in COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

Summary for Tradename: COLESTID

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list12

Pharmacology for Tradename: COLESTID

Clinical Trials for: COLESTID

Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Status: Recruiting Condition: Teriflunomide Elimination; Healthy Volunteers

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
Status: Completed Condition: Hyperlipidemia; Hypercholesterolemia

Familial Atherosclerosis Treatment Study
Status: Completed Condition: Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia

Sorbent Therapy of the Cutaneous Porphyrias
Status: Completed Condition: Erythropoietic Protoporphyria

Cholesterol-Lowering Atherosclerosis Study (CLAS)
Status: Completed Condition: Arterial Occlusive Diseases; Cardiovascular Diseases; Carotid Artery Diseases; Cerebral Arteriosclerosis; Cerebrovascular Disorders; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia; Atherosclerosis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
GRANULE;ORAL017563-003Sep 22, 1995RXNo<disabled><disabled>
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
GRANULE;ORAL017563-004Sep 22, 1995RXYes<disabled><disabled>
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
TABLET;ORAL020222-001Jul 19, 1994RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: COLESTID

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
TABLET;ORAL020222-001Jul 19, 19945,490,987<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: COLESTID

Drugname Dosage Strength RLD Submissiondate
colestipol hydrochlorideTablets1 gColestid8/23/2005
« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc